Recombinant SARS-COV-2 NSP7&NSP8 Protein
Beta LifeScience
SKU/CAT #: BLK-01550P-100UG

SARS-COV-2 NSP7&NSP8 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant SARS-COV-2 NSP7&NSP8 Protein
Beta LifeScience
SKU/CAT #: BLK-01550P-100UG
Collections: Recombinant proteins
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | SARS-COV-2 NSP7&NSP8 Protein is expressed from E.coil with His tag at the C-Terminus.It contains Ser1-Gln83(NSP7)&Ala1-Gln198(NSP8). |
Purity | > 95% as determined by Tris-Bis PAGE |
Accession | YP_009725303.1(NSP7)&YP_009725304.1(NSP8) |
Target Symbol | NSP7&NSP8 |
Synonyms | SP7&NSP8 nsp7&nsp8 |
Species | SARS-CoV-2 |
Expression System | E. coli |
Tag | C-His |
Expression Range | Ser1-Gln83(NSP7) & Ala1-Gln198(NSP8) |
Mol. Weight | The protein has a predicted MW of 32.8 kDa same as Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22um filtered solution in 20mM Tris, 150mM Nacl, 200mM Arginine (pH 8.2). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | The crystal structure of the metabolite of remdesivir (Monophosphate of GS-441524) and NSP12-NSP8-NSP7 of SARS CoV-2 virus was recently reported. The crystal structures of ADP-Ribose or AMP and NSP3 of SARS CoV-2 virus were also released, recently. The crystal structure of NSP3 of SARS CoV-2 virus as an alternative binding site of AMP or ADP-ribose to treat COVID-19. |